John Gordon Freund, Director at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 20 shares at $34.05 ($681) on 2026-05-18, disclosed to the SEC on 2026-05-20.
Seasonal sale ($681) by Director — this insider has traded COLL in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| SIBN | SELL | 2025-08-11 | $388K | — | Filing → |
| COLL | SELL | 2025-06-11 | $404K | — | Filing → |
| SIBN | SELL | 2023-08-11 | $616K | — | Filing → |